Nicolas Chahine

By Nicolas Chahine, InvestorPlace Contributor Jul 20, 2016

Valeant Pharmaceuticals has two distinct, loud sides. I'm willing to risk a few pennies on the long side of VRX stock, and you should be too.

By Nicolas Chahine, InvestorPlace Contributor Jul 19, 2016

Twitter management will probably fumble the ball, but we can still wait out a buyout for free using this trade on TWTR stock.

By Nicolas Chahine, InvestorPlace Contributor Jul 13, 2016

Use Facebook's bullish long-term prospects to finance a shorter-term bearish bet through earnings.

By Nicolas Chahine, InvestorPlace Contributor Jul 11, 2016

This market is bordering on the reckless. While traders have no fear, I can trade the SPDR S&P 500 ETF Trust (SPY) for a 20% yield.

By Nicolas Chahine, InvestorPlace Contributor Jul 6, 2016

BIDU is a cash cow, but I think there is room to capture a move down this summer -- and you can do it for free.

Recent Articles